Globus Medical Stock Analysis (NYSE:GMED)
Globus Medical Analysis Video
View Globus Medical stock analysis video. This is our GMED analyst opinion covering the buy and sell arguments for GMED stock.
Globus Medical Inc Stock Rating (3.9/5)
Our Globus Medical stock opinion is based on fundamentals of the company. This Globus Medical stock analysis is based on latest Q4 earnings for 2016. The stock price analysis takes into account a company's valuation metrics.
Should you buy GMED stock?
- Globus Medical's average operating margin of 27.3% was exceptional.
- LTM Net margins were good at 18.5% for Globus Medical.
- The operating cash flow looks good at 2.1 times the net income.
- Globus Medical's return on invested capital of 20.9% is good.
- Globus Medical has a good Return On Equity (ROE) of 13.4%.
- The company has a healthy free cash flow margin of 24.9%.